PTC Therapeutics Stock (NASDAQ: PTCT) stock price, news, charts, stock research, profile.
You can purchase shares of PTC Therapeutics (NASDAQ:PTCT) through any online brokerage.
Other companies in PTC Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), Ionis Pharmaceuticals (NASDAQ:IONS) and Alkermes (NASDAQ:ALKS).
PTC Therapeutics has a consensus price target of $52.11.
The stock price for PTC Therapeutics (NASDAQ: PTCT) is $50.69 last updated February 21, 2025 at 4:38 PM EST.
There are no upcoming dividends for PTC Therapeutics.
PTC Therapeutics’s Q1 earnings are confirmed for Thursday, April 24, 2025.
There is no upcoming split for PTC Therapeutics.
PTC Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.